Anuncio
Anuncio

RLMD

RLMD logo

Relmada Therapeutics, Inc. Common Stock

4.94
USD
Patrocinado
-0.43
-8.01%
07 ago, 15:59 UTC -4
Cerrado
exchange

Post-mercado

4.96

+0.01
+0.30%

Panorámica financiera de Relmada Therapeutics, Inc. Common Stock

Cap. de Mercado
520.21M
Beta
0.46
Beneficios Por Acción (BPA)
-0.90
Ratio Precio/Valor (P/V) Contable
2.37
Margen de explotación
--
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
-59.03%
Ratio de liquidez
29.52%
Flujo de caja libre
-24.67M
Perfil de RLMD

Gráfico de Beneficios

Beneficios de RLMD

Últimas noticias y pronósticos

Ver todo

Valores en tendencia

Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$133.11
+15.83%
Micron Technology, Inc. logo
Micron Technology, Inc.$877.57
-0.44%
Nvidia Corp logo
Nvidia Corp$223.96
+2.27%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,212.21
-3.68%
Microsoft Corp logo
Microsoft Corp$499.99
+0.03%
Palantir Technologies Inc. Class A Common Stock logo
Palantir Technologies Inc. Class A Common Stock$172.01
+10.32%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$328.58
+2.83%
Anuncio